Select other agents are advisable as different brokers depending on administration concerns and/or adverse influence profile.  Zidovudine combined with lamivudine is the choice NRTI backbone but is connected with a lot more hematologic toxicity. Lopinavir/ritonavir is an alternative PI agent wi